GNRX
VanEck Vectors Generic Drugs ETF
GNRX
GNRX
Delisted
GNRX was delisted on the 4th of April, 2019.
4 hedge funds and large institutions have $287K invested in VanEck Vectors Generic Drugs ETF in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$239K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$22K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$354K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$67.9K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $239K | +$239K | +10,809 | New |
|
|
FDCDDQ
2
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $25.3K | – | – | – |
|
|
3
Bank of America
Charlotte,
North Carolina
| $22K | +$22K | +1,000 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $1K | -$67.9K | -3,395 | -99% |
|
|
5
Citadel Advisors
Miami,
Florida
| – | -$354K | -15,717 | Closed |
|